These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2856853)

  • 61. Assay for erythrocyte uroporphyrinogen I synthase activity, with porphobilinogen as substrate.
    Ford RE; Ou CN; Ellefson RD
    Clin Chem; 1980 Jul; 26(8):1182-5. PubMed ID: 7389090
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Variant of acute intermittent porphyria with normal erythrocyte uroporphyrinogen-I-synthase activity.
    Mustajoki P; Tenhunen R
    Eur J Clin Invest; 1985 Oct; 15(5):281-4. PubMed ID: 3935460
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Heme synthesis in chronic renal failure: the effects of hemodialysis, peritoneal dialysis and erythropoietin treatment.
    Siersema PD; de Rooij FW; Edixhoven-Bosdijk A; Weimar W; Wilson JH
    Nephron; 1995; 71(3):297-302. PubMed ID: 8569978
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of carbamazepine on haem biosynthesis in man.
    Rapeport WG; Connell JC; Thompson GG; Moore MR; Brodie MJ
    Eur J Clin Invest; 1984 Apr; 14(2):107-10. PubMed ID: 6428897
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enzyme abnormalities in the porphyrias.
    Brodie MJ; Moore MR; Goldberg A
    Lancet; 1977 Oct; 2(8040):699-701. PubMed ID: 71507
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [New aspects in the pathogenesis of anemia in chronic polyarthritis].
    Linkesch W; Müller M; Scherak O
    Acta Med Austriaca Suppl; 1979; 6():387-9. PubMed ID: 299239
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients.
    Cannella G; La Canna G; Sandrini M; Gaggiotti M; Nordio G; Movilli E; Mombelloni S; Visioli O; Maiorca R
    Nephrol Dial Transplant; 1991; 6(1):31-7. PubMed ID: 1829146
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Zinc lead-interaction in the rabbit.
    el-Waseef A; Hashim MM
    Acta Med Hung; 1985; 42(3-4):199-207. PubMed ID: 4094843
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Erythrocyte factors concerned in the inhibition of ALA-D by lead.
    Sakai T; Yanagihara S; Ushio K
    Br J Ind Med; 1981 Aug; 38(3):268-74. PubMed ID: 7272240
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Iron and the liver: acute effects of iron-loading on hepatic heme synthesis of rats. Role of decreased activity of 5-aminolevulinate dehydrase.
    Bonkowsky HL; Healey JF; Sinclair PR; Sinclair JF; Shedlofsky SI; Elder GH
    J Clin Invest; 1983 May; 71(5):1175-82. PubMed ID: 6189858
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An evaluation of the use of haem-biosynthetic parameters in the detection of industrial and environmental lead exposure: erythrocyte delta-aminolaevulinate dehydratase and blood protoporphyrin concentrations. [proceedings].
    Meredith PA; Moore MR
    Biochem Soc Trans; 1979 Feb; 7(1):39-41. PubMed ID: 437287
    [No Abstract]   [Full Text] [Related]  

  • 72. Low levels of dehydroascorbic acid in uraemic serum and the partial correction of dehydroascorbic acid deficiency by haemodialysis.
    Bakaev VV; Efremov AV; Tityaev II
    Nephrol Dial Transplant; 1999 Jun; 14(6):1472-4. PubMed ID: 10383010
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relationships between distribution of lead in erythrocytes in vivo and in vitro and inhibition of ALA-D.
    Sakai T; Yanagihara S; Kunugi Y; Ushio K
    Br J Ind Med; 1982 Nov; 39(4):382-7. PubMed ID: 7138797
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of sodium valproate on haem biosynthesis in man: implications for seizure management in the porphyric patient.
    McGuire GM; Macphee GJ; Thompson GG; Moore MR; Brodie MJ
    Eur J Clin Invest; 1988 Feb; 18(1):29-32. PubMed ID: 3130256
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Delta-aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro.
    Gibson SL; Havens JJ; Nguyen ML; Hilf R
    Br J Cancer; 1999 Jun; 80(7):998-1004. PubMed ID: 10362107
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diffuse intermyocardiocytic fibrosis in uraemic patients.
    Mall G; Huther W; Schneider J; Lundin P; Ritz E
    Nephrol Dial Transplant; 1990; 5(1):39-44. PubMed ID: 2109283
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibition of liver, kidney, and erythrocyte delta-aminolevulinic acid dehydratase (porphobilinogen synthase) by gallium in the rat.
    Goering PL; Rehm S
    Environ Res; 1990 Dec; 53(2):135-51. PubMed ID: 2253599
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Behavior of erythrocyte ALA-D activity under the coexistence of zinc and each of other metals (author's transl)].
    Tomokuni K
    Sangyo Igaku; 1978 Sep; 20(5):280-1. PubMed ID: 739642
    [No Abstract]   [Full Text] [Related]  

  • 80. Heme biosynthesis in sideroblastic anemia.
    Pasanen AV; Salmi M; Vuopio P; Tenhunen R
    Int J Biochem; 1980; 12(5-6):969-74. PubMed ID: 7450158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.